Wentworth, John M.Bediaga, Naiara G.Gitelman, Stephen E.Evans-Molina, CarmelaGottlieb, Peter A.Colman, Peter G.Haller, Michael J.Harrison, Leonard C.2022-11-042022-11-042020-04Wentworth JM, Bediaga NG, Gitelman SE, et al. Clinical trial data validate the C-peptide estimate model in type 1 diabetes. Diabetologia. 2020;63(4):885-886. doi:10.1007/s00125-020-05088-6https://hdl.handle.net/1805/30472en-USPublisher PolicyAntilymphocyte serumC-PeptideType 1 Diabetes MellitusArticle